Triveni Turbine Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 10:52 pm

Quick Insight

Triveni Turbine Ltd, a heavy engineering company, currently trades at ₹528 with a market capitalization of ₹16,790 Cr. The company's P/E ratio stands at 49.2, indicating investors are willing to pay a premium for its earnings. Triveni Turbine boasts a robust Return on Equity (ROE) of 30.6% and Return on Capital Employed (ROCE) of 41.4%, well above industry averages. With a healthy Operating Profit Margin (OPM) of 20% and a comfortable Interest Coverage Ratio (ICR) of 178.52x, the company exhibits strong financial performance. Furthermore, its low Borrowings of ₹39 Cr and efficient Cash Conversion Cycle (CCC) of 20 days indicate prudent financial management.

However, Triveni Turbine faces risks such as its relatively high Price-to-Book Value (P/BV) ratio of 14.69x, suggesting the stock may be overvalued compared to industry peers. Additionally, the company's heavy reliance on promoters for ownership at 55.84% raises concerns about potential corporate governance issues. Looking ahead, Triveni Turbine's growth prospects could improve with a diversification strategy into new markets or technologies to mitigate concentration risks in the heavy engineering sector. Conversely, any slowdown in the industrial sector could dampen demand for its products and impact profitability. In conclusion, while Triveni Turbine displays strong financial metrics, investors should carefully monitor industry trends and the company's strategic initiatives to make informed investment decisions.

Competitors of Triveni Turbine Ltd

All Competitor Stocks of Triveni Turbine Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:00 am

Below is a detailed analysis of the quarterly data for Triveni Turbine Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 371.00 Cr.. The value appears to be declining and may need further review. It has decreased from 538.00 Cr. (Mar 2025) to 371.00 Cr., marking a decrease of 167.00 Cr..
• For Expenses, as of Jun 2025, the value is 298.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 418.00 Cr. (Mar 2025) to 298.00 Cr., marking a decrease of 120.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 120.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 46.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 20.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 87.00 Cr.. The value appears to be declining and may need further review. It has decreased from 132.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 45.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 26.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Mar 2025) to 64.00 Cr., marking a decrease of 31.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.03. The value appears to be declining and may need further review. It has decreased from 2.95 (Mar 2025) to 2.03, marking a decrease of 0.92.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:38 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: September 10, 2025, 2:42 pm

Below is a detailed analysis of the balance sheet data for Triveni Turbine Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 928.00 Cr. (Mar 2024) to 1,185.00 Cr., marking an increase of 257.00 Cr..
• For Borrowings, as of Mar 2025, the value is 39.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 39.00 Cr., marking an increase of 36.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 783.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 707.00 Cr. (Mar 2024) to 783.00 Cr., marking an increase of 76.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,039.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,670.00 Cr. (Mar 2024) to 2,039.00 Cr., marking an increase of 369.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 323.00 Cr.. The value appears strong and on an upward trend. It has increased from 283.00 Cr. (Mar 2024) to 323.00 Cr., marking an increase of 40.00 Cr..
• For CWIP, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 18.00 Cr..
• For Investments, as of Mar 2025, the value is 348.00 Cr.. The value appears to be declining and may need further review. It has decreased from 458.00 Cr. (Mar 2024) to 348.00 Cr., marking a decrease of 110.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,348.00 Cr.. The value appears strong and on an upward trend. It has increased from 928.00 Cr. (Mar 2024) to 1,348.00 Cr., marking an increase of 420.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,039.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,670.00 Cr. (Mar 2024) to 2,039.00 Cr., marking an increase of 369.00 Cr..

Notably, the Reserves (1,185.00 Cr.) exceed the Borrowings (39.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Triveni Turbine Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 8.47 (Mar 24) to 11.28, marking an increase of 2.81.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from 8.47 (Mar 24) to 11.28, marking an increase of 2.81.
• For Cash EPS (Rs.), as of Mar 25, the value is 12.10. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 12.10, marking an increase of 2.97.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 38.25. It has increased from 30.24 (Mar 24) to 38.25, marking an increase of 8.01.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 38.25. It has increased from 30.24 (Mar 24) to 38.25, marking an increase of 8.01.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 63.08. It has increased from 52.03 (Mar 24) to 63.08, marking an increase of 11.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.28. This value is within the healthy range. It has increased from 11.99 (Mar 24) to 16.28, marking an increase of 4.29.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.45. This value is within the healthy range. It has increased from 11.33 (Mar 24) to 15.45, marking an increase of 4.12.
• For PBT / Share (Rs.), as of Mar 25, the value is 15.36. This value is within the healthy range. It has increased from 11.25 (Mar 24) to 15.36, marking an increase of 4.11.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 11.27. This value is within the healthy range. It has increased from 8.47 (Mar 24) to 11.27, marking an increase of 2.80.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.23. This value is within the healthy range. It has increased from 8.47 (Mar 24) to 11.23, marking an increase of 2.76.
• For PBDIT Margin (%), as of Mar 25, the value is 25.81. This value is within the healthy range. It has increased from 23.03 (Mar 24) to 25.81, marking an increase of 2.78.
• For PBIT Margin (%), as of Mar 25, the value is 24.49. This value exceeds the healthy maximum of 20. It has increased from 21.78 (Mar 24) to 24.49, marking an increase of 2.71.
• For PBT Margin (%), as of Mar 25, the value is 24.35. This value is within the healthy range. It has increased from 21.62 (Mar 24) to 24.35, marking an increase of 2.73.
• For Net Profit Margin (%), as of Mar 25, the value is 17.87. This value exceeds the healthy maximum of 10. It has increased from 16.28 (Mar 24) to 17.87, marking an increase of 1.59.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 17.80. This value is within the healthy range. It has increased from 16.27 (Mar 24) to 17.80, marking an increase of 1.53.
• For Return on Networth / Equity (%), as of Mar 25, the value is 29.36. This value is within the healthy range. It has increased from 28.04 (Mar 24) to 29.36, marking an increase of 1.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 38.61. This value is within the healthy range. It has increased from 36.57 (Mar 24) to 38.61, marking an increase of 2.04.
• For Return On Assets (%), as of Mar 25, the value is 17.69. This value is within the healthy range. It has increased from 16.27 (Mar 24) to 17.69, marking an increase of 1.42.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.22. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 2.22, marking an increase of 0.23.
• For Quick Ratio (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 1.96, marking an increase of 0.31.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.46. This value is within the healthy range. It has increased from 4.03 (Mar 24) to 4.46, marking an increase of 0.43.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 27.16 (Mar 24) to 0.00, marking a decrease of 27.16.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 25.22 (Mar 24) to 0.00, marking a decrease of 25.22.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 72.84 (Mar 24) to 0.00, marking a decrease of 72.84.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.78 (Mar 24) to 0.00, marking a decrease of 74.78.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 178.52. This value is within the healthy range. It has increased from 143.35 (Mar 24) to 178.52, marking an increase of 35.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 124.62. This value is within the healthy range. It has increased from 102.32 (Mar 24) to 124.62, marking an increase of 22.30.
• For Enterprise Value (Cr.), as of Mar 25, the value is 17,548.20. It has increased from 16,667.08 (Mar 24) to 17,548.20, marking an increase of 881.12.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.75. This value exceeds the healthy maximum of 3. It has decreased from 10.08 (Mar 24) to 8.75, marking a decrease of 1.33.
• For EV / EBITDA (X), as of Mar 25, the value is 33.90. This value exceeds the healthy maximum of 15. It has decreased from 43.74 (Mar 24) to 33.90, marking a decrease of 9.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.91. This value exceeds the healthy maximum of 3. It has decreased from 10.32 (Mar 24) to 8.91, marking a decrease of 1.41.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 72.83 (Mar 24) to 0.00, marking a decrease of 72.83.
• For Price / BV (X), as of Mar 25, the value is 14.69. This value exceeds the healthy maximum of 3. It has decreased from 17.78 (Mar 24) to 14.69, marking a decrease of 3.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.91. This value exceeds the healthy maximum of 3. It has decreased from 10.32 (Mar 24) to 8.91, marking a decrease of 1.41.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness